Wanbury Limited Cash Flow Conversion Efficiency
Wanbury Limited cash flow conversion efficiency. Based on the latest financial reports, Wanbury Limited (WANBURY) has a cash flow conversion efficiency ratio of -0.053x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Rs-56.53 Million ≈ $-611.33K USD) by net assets (Rs1.07 Billion ≈ $11.60 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Cash Flow Conversion Efficiency of Wanbury Limited (2006–2025)
Cash flow conversion efficiency of Wanbury Limited from 2006 to 2025. This chart illustrates how Wanbury Limited's cash flow conversion efficiency has evolved over time, based on yearly financial data. View Wanbury Limited stock price for real-time trading data and today's change.
Wanbury Limited Cash Flow Conversion Ratio Explained
Wanbury Limited cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.
Wanbury Limited Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Wanbury Limited ranked by their cash flow conversion efficiency. Also see Wanbury Limited stock valuation for the company's overall valuation and market capitalisation.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Unitech Electronics Co. Ltd.
TW:3652
|
-0.005x |
|
Holland Colours NV
AS:HOLCO
|
-0.010x |
|
Metrofile
JSE:MFL
|
0.237x |
|
Recce Pharmaceuticals Ltd
AU:RCE
|
-0.020x |
|
Arena Group Holdings Inc
NYSE MKT:AREN
|
-2.718x |
|
SKY E&M Co. Ltd
KQ:131100
|
0.027x |
|
Selectquote Inc
NYSE:SLQT
|
0.074x |
|
Mordechai Aviv Taasiot Beniyah 1973 Ltd
TA:AVIV
|
-0.019x |
Annual Cash Flow Conversion Efficiency for Wanbury Limited (2006–2025)
The table below shows the annual cash flow conversion efficiency of Wanbury Limited from 2006 to 2025. Review WANBURY free cash flow to operating cash ratio to assess how much free cash flow the company generates relative to operating cash flow.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-03-31 | Rs592.72 Million ≈ $6.41 Million |
Rs261.02 Million ≈ $2.82 Million |
0.440x | +209.30% |
| 2024-03-31 | Rs279.41 Million ≈ $3.02 Million |
Rs39.78 Million ≈ $430.23K |
0.142x | +123.60% |
| 2023-03-31 | Rs-328.16 Million ≈ $-3.55 Million |
Rs197.97 Million ≈ $2.14 Million |
-0.603x | +65.13% |
| 2022-03-31 | Rs-234.20 Million ≈ $-2.53 Million |
Rs405.23 Million ≈ $4.38 Million |
-1.730x | -1520.63% |
| 2021-03-31 | Rs-1.56 Billion ≈ $-16.90 Million |
Rs166.81 Million ≈ $1.80 Million |
-0.107x | +65.30% |
| 2020-03-31 | Rs-1.43 Billion ≈ $-15.51 Million |
Rs441.33 Million ≈ $4.77 Million |
-0.308x | -116.56% |
| 2019-03-31 | Rs-2.09 Billion ≈ $-22.63 Million |
Rs297.31 Million ≈ $3.22 Million |
-0.142x | +18.93% |
| 2018-03-31 | Rs-1.85 Billion ≈ $-19.97 Million |
Rs323.65 Million ≈ $3.50 Million |
-0.175x | +38.09% |
| 2017-03-31 | Rs-1.53 Billion ≈ $-16.58 Million |
Rs433.86 Million ≈ $4.69 Million |
-0.283x | -7.32% |
| 2016-03-31 | Rs-1.63 Billion ≈ $-17.65 Million |
Rs430.53 Million ≈ $4.66 Million |
-0.264x | -16.35% |
| 2015-03-31 | Rs-1.77 Billion ≈ $-19.16 Million |
Rs401.67 Million ≈ $4.34 Million |
-0.227x | +17.67% |
| 2014-03-31 | Rs-1.65 Billion ≈ $-17.85 Million |
Rs454.48 Million ≈ $4.92 Million |
-0.275x | +92.09% |
| 2013-03-31 | Rs-212.95 Million ≈ $-2.30 Million |
Rs741.21 Million ≈ $8.02 Million |
-3.481x | -980.07% |
| 2012-03-31 | Rs711.13 Million ≈ $7.69 Million |
Rs281.25 Million ≈ $3.04 Million |
0.395x | +747.00% |
| 2011-03-31 | Rs1.05 Billion ≈ $11.35 Million |
Rs49.02 Million ≈ $530.13K |
0.047x | -78.40% |
| 2010-03-31 | Rs1.92 Billion ≈ $20.81 Million |
Rs416.05 Million ≈ $4.50 Million |
0.216x | -52.49% |
| 2009-03-31 | Rs1.58 Billion ≈ $17.13 Million |
Rs720.95 Million ≈ $7.80 Million |
0.455x | +318.55% |
| 2007-03-31 | Rs1.29 Billion ≈ $13.96 Million |
Rs-268.83 Million ≈ $-2.91 Million |
-0.208x | -346.01% |
| 2006-03-31 | Rs1.01 Billion ≈ $10.94 Million |
Rs-47.21 Million ≈ $-510.60K |
-0.047x | -- |
About Wanbury Limited
Wanbury Limited manufactures and sells formulations and active pharmaceutical ingredients (API) in India and internationally. The company offers formulations for anti-infectives, pain and analgesics, respiratory, gastroenterology, gynecology, rheumatology, and central nervous system, as well as for vitamins, minerals, and nutrition. It also provides API products for antidiabetics, antihistamines,… Read more